Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
STOUGHTON, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report third quarter 2024 financial results after the market closes on Thursday, November 7, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.
馬薩諸塞州斯托頓,2024年10月24日(環球新聞社)-- Collegium Pharmaceutical(納斯達克:COLL),一家領先的多元化特殊藥品公司,致力於改善患有嚴重醫療狀況的人們的生活,今天宣佈將於2024年11月7日星期四市場收盤後公佈第三季度2024年財務結果。在財務報告發布後,公司將於東部時間下午4:30舉行現場電話會議和網絡直播。
Conference Call Information
To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the "Collegium Pharmaceutical Q3 2024 Earnings Call." An audio webcast will be accessible from the Investors section of the Company's website: . The webcast will be available for replay on the Company's website approximately two hours after the event.
電話會議信息
要參加電話會議,請撥打(877)407-8037(美國)或(201)689-8037(國際),並提及「Collegium Pharmaceutical Q3 2024業績會」。音頻網絡直播將可從公司網站的投資者版塊訪問: 。 網絡直播將在活動結束約兩小時後在公司網站上提供回放。
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium's headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company's website at .
關於 Collegium Pharmaceutical, Inc.
Collegium是一家領先的多元化特殊藥品公司,致力於改善患有嚴重醫療狀況的人們的生活。 Collegium的總部位於馬薩諸塞州斯托頓。 欲了解更多信息,請訪問公司網站: 。
Investor Contact:
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
投資者聯繫:
Danielle Jesse
投資者關係董事
ir@collegiumpharma.com
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com
媒體聯繫人:
Marissa Samuels
企業通信副總裁
communications@collegiumpharma.com
譯文內容由第三人軟體翻譯。